JP2009538268A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538268A5
JP2009538268A5 JP2008553964A JP2008553964A JP2009538268A5 JP 2009538268 A5 JP2009538268 A5 JP 2009538268A5 JP 2008553964 A JP2008553964 A JP 2008553964A JP 2008553964 A JP2008553964 A JP 2008553964A JP 2009538268 A5 JP2009538268 A5 JP 2009538268A5
Authority
JP
Japan
Prior art keywords
pioglitazone
salt
alkali metal
metal chloride
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008553964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538268A (ja
JP5162475B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008553964A priority Critical patent/JP5162475B2/ja
Priority claimed from JP2008553964A external-priority patent/JP5162475B2/ja
Publication of JP2009538268A publication Critical patent/JP2009538268A/ja
Publication of JP2009538268A5 publication Critical patent/JP2009538268A5/ja
Application granted granted Critical
Publication of JP5162475B2 publication Critical patent/JP5162475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008553964A 2006-05-23 2007-05-22 ピオグリタゾンを含有する経口剤 Active JP5162475B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008553964A JP5162475B2 (ja) 2006-05-23 2007-05-22 ピオグリタゾンを含有する経口剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006143390 2006-05-23
JP2006143390 2006-05-23
JP2008553964A JP5162475B2 (ja) 2006-05-23 2007-05-22 ピオグリタゾンを含有する経口剤
PCT/JP2007/060756 WO2007136129A1 (en) 2006-05-23 2007-05-22 Oral preparation comprising pioglitazone

Publications (3)

Publication Number Publication Date
JP2009538268A JP2009538268A (ja) 2009-11-05
JP2009538268A5 true JP2009538268A5 (enExample) 2010-06-24
JP5162475B2 JP5162475B2 (ja) 2013-03-13

Family

ID=38294162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008553964A Active JP5162475B2 (ja) 2006-05-23 2007-05-22 ピオグリタゾンを含有する経口剤

Country Status (14)

Country Link
US (1) US8865217B2 (enExample)
EP (1) EP2019669B1 (enExample)
JP (1) JP5162475B2 (enExample)
KR (1) KR20090024181A (enExample)
CN (2) CN103520158B (enExample)
AR (1) AR061070A1 (enExample)
AT (1) ATE534374T1 (enExample)
CA (1) CA2653786C (enExample)
CL (1) CL2007001457A1 (enExample)
ES (1) ES2377839T3 (enExample)
MY (1) MY146781A (enExample)
PE (1) PE20080180A1 (enExample)
TW (1) TWI407959B (enExample)
WO (1) WO2007136129A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
US20120058205A1 (en) * 2009-03-04 2012-03-08 Walter Howard Peschel Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
WO2010119851A1 (ja) * 2009-04-14 2010-10-21 ライオン株式会社 口腔内崩壊錠
US10071059B2 (en) * 2009-12-18 2018-09-11 Frieslandcampina Nederland Holding B.V. Co-processed tablet excipient composition its preparation and use
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
JP5630902B2 (ja) * 2010-08-26 2014-11-26 沢井製薬株式会社 ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
WO2012029838A1 (ja) * 2010-08-31 2012-03-08 協和発酵キリン株式会社 口腔内崩壊錠
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
AU2014236510A1 (en) 2013-03-14 2015-09-24 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
JP6574556B2 (ja) * 2014-08-27 2019-09-11 日東電工株式会社 口腔内フィルム状基剤及び製剤
CN104174022B (zh) * 2014-09-16 2018-10-16 过冬 一种吡格列酮的苦味抑制剂和包含吡格列酮的口服制剂
JP2018012697A (ja) * 2016-07-11 2018-01-25 大原薬品工業株式会社 口腔内崩壊時間が短縮された、塩を含有する錠剤
US20210386726A1 (en) * 2020-06-11 2021-12-16 Chang Gung University Method for inhibiting coronavirus infection and replication
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2809301B2 (ja) * 1993-12-09 1998-10-08 田辺製薬株式会社 苦味隠蔽された経口投与製剤
CN1059320C (zh) * 1994-04-07 2000-12-13 段永聚 一种无糖型草珊瑚含片
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US7135485B2 (en) * 2001-09-28 2006-11-14 Teva Pharmaceutical Industries Ltd. Pioglitazone hydrochloride
JP2003183162A (ja) * 2001-12-17 2003-07-03 Sumitomo Pharmaceut Co Ltd シメチジン経口製剤
US20030220374A1 (en) * 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
WO2003075919A1 (fr) 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie seche)
US20050131027A1 (en) * 2002-03-21 2005-06-16 Guy Samburski Fine particle size pioglitazone
KR20100137023A (ko) * 2002-09-20 2010-12-29 안드렉스 랩스 엘엘씨 약제학적 정제
KR20070011497A (ko) * 2004-05-11 2007-01-24 산텐 세이야꾸 가부시키가이샤 각결막 장해 치료제
KR100843508B1 (ko) * 2004-09-29 2008-07-04 모리나가 뉴교 가부시키가이샤 고혈당 개선용 의약
HRP20160679T1 (hr) 2005-12-22 2016-07-15 Takeda Pharmaceutical Company Limited Kruti pripravak koji sadrži senzibilizator inzulina
JP5276991B2 (ja) 2006-04-27 2013-08-28 武田薬品工業株式会社 固形製剤

Similar Documents

Publication Publication Date Title
JP2009538268A5 (enExample)
JP2010047612A5 (enExample)
JP2008504257A5 (enExample)
PE20080180A1 (es) Preparacion oral de pioglitazona
JP2012031131A5 (enExample)
HRP20240317T1 (hr) Liječenje hepatičke encefalopatije uporabom rifaksimina
JP2010522242A5 (enExample)
JP2010529999A5 (enExample)
JP2013505928A5 (enExample)
TWI526210B (zh) Oral pharmaceutical composition
HRP20161444T1 (hr) Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
JP2012508784A5 (enExample)
JP2011519967A5 (enExample)
MX2009014193A (es) Preparacion farmaceutica solida que comprende benzazepinas y metodo de produccion de la misma.
JP2007517039A5 (enExample)
JP2011506587A5 (enExample)
JP2012500261A5 (enExample)
WO2014192918A1 (ja) 口腔貼付剤
JP2008515980A5 (enExample)
TWI455732B (zh) 經口粉粒狀抗腫瘤劑
JP2010504840A5 (enExample)
JP2008500287A5 (enExample)
JP2016210758A5 (enExample)
JP2009149532A5 (enExample)
JP2014504628A5 (enExample)